When different healthcare stakeholders have goals that align, patients can stand to benefit. Access this resource today to discover what life sciences organizations can do to help get critical conversations started. This valuable guide will help in developing a roadmap for better, more productive healthcare stakeholder partnerships that can improve patient health and close gaps in care.
When starting gets easy, share is no longer won at the counter. It is kept on the Tuesdays, one refill at a time, inside the system that can tell you whether the patient came back.
Why pharma brands need to measure movement in the patient journey, not just media response
A roadmap for how life science organizations can initiate and support more productive relationships between disparate stakeholders to enhance patient care and health
One in five people with Type 2 diabetes is living with dangerously high blood sugar levels. Without timely intervention, millions face a fast track to life-altering complications.
Within the Essence Patient Solutions network alone, 2.24 million people are living with Chronic Heart Failure. That’s 2.24 million lives teetering on the edge, millions who could face avoidable decline or death without the right intervention.
Despite clear guidelines and proven therapies, osteoporosis remains one of the most undertreated chronic conditions among women over 50. It’s also one of the most actionable opportunities for pharmaceutical brands.
Nearly two million CKD patients in our network are silently progressing toward kidney failure. Most don’t know it. With earlier activation, we can change the course of their disease and save lives.
More than three million migraine patients across the Essence network are waiting for access to guideline-recommended treatments that could transform their lives.